Suppliers and packagers for prednisolone

prednisolone

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Chartwell Rx	PREDNISOLONE	prednisolone	SOLUTION;ORAL	040323	ANDA	Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.	23155-927-51	240 mL in 1 BOTTLE (23155-927-51)	2025-03-01
Chartwell Rx	PREDNISOLONE	prednisolone	SOLUTION;ORAL	040323	ANDA	Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.	23155-927-52	480 mL in 1 BOTTLE (23155-927-52)	2025-03-01
Chartwell Rx	PREDNISOLONE	prednisolone	SOLUTION;ORAL	040323	ANDA	Chartwell RX, LLC	62135-250-24	2 TRAY in 1 BOX (62135-250-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (62135-250-45)	2022-11-20
Chartwell Rx	PREDNISOLONE	prednisolone	SOLUTION;ORAL	040323	ANDA	Chartwell RX, LLC	62135-250-37	240 mL in 1 BOTTLE (62135-250-37)	2022-11-20

PREDNISOLONE API Suppliers and Market Landscape

Last updated: February 19, 2026

This analysis identifies key suppliers of prednisolone active pharmaceutical ingredient (API), outlines the regulatory environment governing its production, and assesses market dynamics relevant to procurement and R&D. Prednisolone, a synthetic corticosteroid, is a widely prescribed anti-inflammatory and immunosuppressant drug used for various conditions including asthma, allergies, and autoimmune diseases.

What is the Global Prednisolone API Market Size and Growth Projection?

The global prednisolone API market is projected to reach USD 1.65 billion by 2028, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2023 to 2028. This growth is driven by the increasing prevalence of inflammatory and autoimmune diseases, alongside expanding healthcare access in emerging economies. The market is segmented by therapeutic application, with anti-inflammatory applications dominating demand. Geographically, North America and Europe currently hold the largest market shares due to established healthcare infrastructures and high prescription rates. The Asia-Pacific region is anticipated to witness the fastest growth, fueled by increasing healthcare spending and rising disease incidence.

Region	2023 Market Share (Est.)	Projected CAGR (2023-2028)
North America	30%	3.8%
Europe	28%	4.0%
Asia-Pacific	25%	5.1%
Latin America	10%	4.5%
Middle East & Africa	7%	4.2%

Who are the Leading Prednisolone API Manufacturers?

Several manufacturers supply prednisolone API globally. These companies vary in scale, geographic presence, and regulatory compliance. Key players include:

• Pfizer Inc.: A multinational pharmaceutical corporation with a significant presence in API manufacturing, including corticosteroids.
• Teva Pharmaceutical Industries Ltd.: A leading generic drug manufacturer with a broad API portfolio, encompassing prednisolone.
• Mylan N.V. (now Viatris): A global healthcare company that produces a wide range of APIs, including those for corticosteroid formulations.
• Sun Pharmaceutical Industries Ltd.: An Indian multinational pharmaceutical company with substantial API manufacturing capabilities, serving global markets.
• Lupin Limited: Another prominent Indian pharmaceutical company with a strong focus on API production for various therapeutic areas.
• Dr. Reddy's Laboratories: A global pharmaceutical company based in India, involved in the development and manufacturing of complex APIs.
• Divi's Laboratories: An Indian API manufacturer known for its large-scale production and regulatory adherence, supplying to major pharmaceutical companies.
• CheMondis GmbH: A digital B2B marketplace for chemicals, where various API suppliers, including those for prednisolone, list their products. This platform facilitates access to a wider network of manufacturers.
• Siegfried AG: A Swiss company specializing in the development and manufacturing of small molecules and sterile injectable products, with capabilities in corticosteroid API synthesis.
• AbbVie Inc.: While known for its branded biologics, AbbVie also has a history of small molecule production and supply chain management that may include corticosteroids.

These manufacturers operate under stringent quality control measures to meet pharmacopoeial standards. The supply chain involves raw material sourcing, chemical synthesis, purification, and quality testing.

What are the Key Regulatory Requirements for Prednisolone API Production?

The production and supply of prednisolone API are governed by strict regulatory frameworks to ensure product safety, efficacy, and quality. Key regulatory bodies and requirements include:

• Food and Drug Administration (FDA) - United States: Manufacturers supplying to the US market must adhere to FDA regulations, including Good Manufacturing Practices (GMP). Facilities are subject to inspection.
• European Medicines Agency (EMA) - European Union: API manufacturers must comply with EU GMP guidelines, which are harmonized across member states. Certificates of Suitability to the monographs of the European Pharmacopoeia (CEP) are often required.
• Pharmaceuticals and Medical Devices Agency (PMDA) - Japan: Japanese regulations also mandate GMP compliance and rigorous quality standards for API imports and domestic production.
• World Health Organization (WHO): WHO prequalification program ensures that APIs meet international quality standards, particularly for procurement by UN agencies and developing countries.
• Pharmacopoeial Standards: Prednisolone API must meet specifications outlined in major pharmacopoeias, such as the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and Japanese Pharmacopoeia (JP). These monographs define identity, purity, assay, and impurity limits.
• Drug Master Files (DMFs): Manufacturers often submit DMFs to regulatory agencies. These confidential documents provide detailed information about the API manufacturing process, facility, and controls, allowing regulatory bodies to review the API's quality without disclosing proprietary information to the drug product manufacturer.
• ICH Guidelines: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines, such as ICH Q7 (Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients), are critical for global API manufacturers.

Compliance with these regulations necessitates robust quality management systems, validated manufacturing processes, comprehensive analytical testing, and thorough documentation.

What are the Primary Manufacturing Processes and Challenges for Prednisolone API?

Prednisolone is typically synthesized through a multi-step chemical process. Key steps often involve the modification of precursor steroids, such as hydrocortisone or cortisol, through oxidation, reduction, and specific functional group introductions.

Core Synthesis Steps (Generalized):

1. Starting Material: Often derived from diosgenin or other phytosterols, or through semi-synthesis from more readily available steroid precursors.
2. Introduction of Double Bonds: Creating the $\Delta^1$ double bond in the A ring, characteristic of prednisolone, is a crucial step. This is commonly achieved through microbial dehydrogenation or chemical oxidation methods.
3. Hydroxylation: Ensuring the presence of hydroxyl groups at C11, C17, and C21.
4. Oxidation/Reduction: Adjusting oxidation states at various positions, particularly at C3 and C20, to achieve the ketone and $\beta$-ketol side chain characteristic of prednisolone.
5. Purification: Crystallization, chromatography, and other purification techniques are essential to achieve high purity levels, remove process impurities, and meet pharmacopoeial standards.

Key Manufacturing Challenges:

• Stereochemical Control: Steroid synthesis involves multiple chiral centers. Maintaining precise stereochemistry throughout the synthesis is critical for API efficacy and safety.
• Impurity Profiling and Control: Identifying, quantifying, and controlling process-related impurities and degradation products is paramount. Regulatory agencies have strict limits on specific impurities.
• Yield Optimization: Multi-step synthesis can lead to lower overall yields. Optimizing reaction conditions and minimizing losses at each step is economically important.
• Scale-Up: Transitioning from laboratory-scale synthesis to commercial-scale production requires significant process development and engineering expertise to maintain quality and consistency.
• Regulatory Compliance: Maintaining compliance with evolving GMP standards and pharmacopoeial requirements across different global markets is an ongoing challenge.
• Raw Material Sourcing: Securing reliable and consistent sources of high-quality starting materials and reagents is crucial. Fluctuations in the availability or price of precursors can impact production.
• Environmental Impact: Chemical synthesis can generate waste. Developing greener synthesis routes and efficient waste management practices are increasingly important.

How Does the Supply Chain for Prednisolone API Function?

The prednisolone API supply chain is a complex, global network involving multiple stakeholders:

1. Raw Material Suppliers: Providers of basic steroid precursors, chemical reagents, and solvents.
2. API Manufacturers: Companies that synthesize and purify prednisolone API according to GMP standards. These can be integrated pharmaceutical companies or specialized API manufacturers.
3. Contract Manufacturing Organizations (CMOs)/Contract Development and Manufacturing Organizations (CDMOs): Some drug product manufacturers outsource API synthesis to CMOs/CDMOs.
4. Distributors and Traders: Entities that facilitate the movement of API from manufacturers to drug product formulators, often handling logistics and regulatory documentation.
5. Drug Product Manufacturers: Pharmaceutical companies that purchase prednisolone API to formulate into finished dosage forms (tablets, injections, creams).
6. Regulatory Bodies: Agencies that oversee quality, safety, and approval throughout the supply chain.

Supply Chain Dynamics:

• Global Sourcing: A significant portion of API manufacturing, including for prednisolone, is concentrated in countries like India and China due to cost advantages and established chemical synthesis infrastructure.
• Dual Sourcing Strategies: To mitigate risks of supply disruption, many drug product manufacturers seek to qualify multiple API suppliers.
• Geopolitical Factors: Trade policies, tariffs, and political stability in manufacturing regions can impact supply chain reliability and cost.
• Quality Audits: Drug product manufacturers conduct rigorous quality audits of their API suppliers to ensure compliance with GMP and internal standards.
• Lead Times: The time from order placement to API delivery can vary significantly based on manufacturer capacity, inventory levels, and shipping logistics. Typical lead times can range from 4 to 12 weeks.
• Inventory Management: Maintaining adequate API inventory is critical for uninterrupted drug production, balancing holding costs against the risk of stock-outs.

What are the Future Trends and Opportunities in the Prednisolone API Market?

Several trends are shaping the future of the prednisolone API market:

• Increased Demand for High-Purity API: As regulatory scrutiny intensifies, there is a growing emphasis on APIs with minimal impurities and well-defined impurity profiles.
• Green Chemistry Initiatives: Development of more environmentally sustainable synthesis routes, reducing solvent use and waste generation. This includes exploring enzymatic or biocatalytic approaches.
• Continuous Manufacturing: Adoption of continuous manufacturing processes for API production offers potential benefits in terms of efficiency, consistency, and reduced footprint compared to traditional batch manufacturing.
• Supply Chain Resilience: Post-pandemic, there is a heightened focus on diversifying supply chains and building resilience against disruptions. This may lead to increased regional manufacturing or multi-regional sourcing strategies.
• Technological Advancements: Innovations in process analytical technology (PAT) and automation can improve real-time monitoring and control of manufacturing processes, leading to enhanced quality and efficiency.
• Emerging Markets Growth: The rising prevalence of chronic inflammatory diseases and expanding healthcare access in emerging economies present significant growth opportunities.
• Specialized Formulations: While prednisolone is a mature API, there may be opportunities in developing APIs suitable for novel drug delivery systems or specialized formulations requiring specific particle size or polymorphic forms.

Key Takeaways

The global prednisolone API market is robust, driven by consistent demand for corticosteroid therapy. Leading manufacturers are geographically diverse, with a significant presence in Asia. Regulatory compliance, particularly adherence to GMP standards and pharmacopoeial monographs, is non-negotiable. Key challenges in API production include stereochemical control, impurity management, and yield optimization. The supply chain is global, necessitating robust risk management strategies. Future growth will likely be influenced by an increasing demand for high-purity APIs, the adoption of sustainable manufacturing practices, and the expansion of healthcare in emerging markets.

Frequently Asked Questions

1. What is the primary therapeutic use of prednisolone API? Prednisolone API is primarily used to produce finished drug products that act as anti-inflammatory and immunosuppressant agents.

2. Which regulatory body's standards are most critical for US-bound prednisolone API? The US Food and Drug Administration (FDA) standards, including current Good Manufacturing Practices (cGMP) and adherence to USP monographs, are most critical.

3. What is the typical duration for qualifying a new prednisolone API supplier? The qualification process, including audits, documentation review, and sample testing, can typically take 6 to 12 months.

4. How do advancements in biocatalysis impact prednisolone API synthesis? Biocatalysis can offer more selective and environmentally friendly routes for specific chemical transformations in steroid synthesis, potentially improving yields and reducing byproducts.

5. Are there any significant price trends for prednisolone API currently? While specific pricing fluctuates based on supply, demand, and raw material costs, the market for generic APIs like prednisolone generally experiences competitive pricing due to multiple suppliers.

Citations

[1] Grand View Research. (2023). Prednisolone API Market Size, Share & Trends Analysis Report By Therapeutic Application (Anti-inflammatory, Immunosuppressants), By Region, And Segment Forecasts, 2023 - 2030. [2] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (2000). ICH Harmonised Tripartite Guideline: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients Q7. [3] United States Pharmacopeial Convention. USP Monographs: Prednisolone. [4] European Directorate for the Quality of Medicines & HealthCare. Certificate of Suitability to the Monographs of the European Pharmacopoeia (CEP).